Physician profile
Raimundo Leon
NPI 1508905134
$844.59
in general payments reported to CMS, 2019-2025
11 companies · $33.60 in 2025
The $33.60 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $141 · 2020: $43.60 · 2021: $452 · 2022: $110 · 2023: $41.60 · 2024: $22.84 · 2025: $33.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $98.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $98.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $216.49 | 2020-2021 | |
| Celularity INC. | $136.70 | 2021 | |
| Relievant Medsystems, INC. | $112.87 | 2021 | |
| Nevro Corp. | $98.73 | 2022-2024 | Senza |
| Boston Scientific Corporation | $93.85 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $55.26 | 2019 | |
| Nalu Medical, INC. | $39.78 | 2022 | |
| Protega Pharmaceutials INC | $33.60 | 2025 | Roxybond |
| Johnson & Johnson Surgical Vision, INC. | $32.63 | 2019-2020 | |
| Almatica Pharma LLC | $12.84 | 2021 | |
| Arbor Pharmaceuticals, INC. | $11.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raimundo Leon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.